Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TH5427 is a lead NUDT5 inhibitor(MG assay IC50 = 29 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 182.00 | |
2 mg | In stock | $ 252.00 | |
5 mg | In stock | $ 388.00 | |
10 mg | In stock | $ 577.00 | |
25 mg | In stock | $ 926.00 | |
50 mg | In stock | $ 1,260.00 | |
100 mg | In stock | $ 1,680.00 | |
500 mg | In stock | $ 3,380.00 |
Description | TH5427 is a lead NUDT5 inhibitor(MG assay IC50 = 29 nM). |
Targets&IC50 | NUDT5:29 nM(MG assay) |
In vitro | In HL-60 cell lysates, TH5427(20?μM) stabilized NUDT5 to nearly the same levels as observed in the 37?°C DMSO control. TH5427 was the most potent stabilizer under the described conditions with an apparent EC50 of 2.1?μM. Accordingly, TH5427 had a positive, dose-dependent shift in the apparent Tagg—the temperature at which 50 % of the target protein denatures and aggregates (TH5427 shifted NUDT5 Tagg up to?≈?8?°C)[1]. |
Molecular Weight | 491.33 |
Formula | C20H20Cl2N8O3 |
CAS No. | 2253744-56-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 3.67 mg/mL (7.46 mM), Sonification is recommended
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TH5427 2253744-56-6 Metabolism NUDIX hydrolase inhibit breast cancer TH 5427 proliferation Inhibitor NUDT5 ATP synthesis progestin-dependent ADP-ribose TH-5427 inhibitor